¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium lactate solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alkaline solution
    ¾ËÄ®¸®¿ë¾×
  • bleaching solution
    Ç¥¹é¿ë¾×
  • balanced salt solution
    ÆòÇü¿°¾×
  • bromine solution
    ºê·Ò¿ë¾×
  • buffer solution
    ¿ÏÃæ¾×
  • Burow¡¯s solution
    ºÎ·Î¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×
  • crystalloid solution
    °áÁ¤Áú¿ë¾×
  • culture solution
    ¹è¾ç¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×
  • disclosing solution
    1. Ä¡ÅÂÂø»ö¾× 2. ³ëÃâ¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bromine solution
    ºê·Ò¿ë¾×
  • buffer solution
    ¿ÏÃæ¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×, ½ÉÀ帶ºñ¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×, ±³Áú¿ë¾×
  • conjugate solution
    ¦¿ë¾×
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Hayem s solution
    ¾ÆÀ̾ä¿ë¾×.
  • Heidenhain s hematoxylin staining solution
    ÇÏÀ̵§ÇÏÀÎ Ç츶Åå½Ç¸° ¿°»ö¾×.
  • Locke s solution
    ·ÎÅ©¾×.
  • Lockes solution
    ·ÎÅ©¾×
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • iodophthalein sodium
    °¡¿ë¼º(ʦéÁàõ) ¿äµå ÇÁÅ»·¹ÀÎ.
  • low sodium syndrome
    Àú³ªÆ®·ýÁõÈıº(­ñøý¦ÏØ).
  • meralluride sodium
    ¸Þ¶ö·ç¶óÀ̵峪Ʈ·ý.
  • natrium =sodium
    ³ªÆ®·ý.
  • nonexchangeable sodium
    ºñ±³È¯¼º ³ªÆ®·ý.
  • phethenylate sodium
    ÆäÅ×´Ò·¹ÀÌÆ®³ªÆ®·ý.
  • simple sodium depletion
    ´Ü¼øNa<³ªÆ®·ý>ºÎÁ·.
  • soda = sodium bicarbonate
  • sodium
    ¼Òµð¿ò
  • sodium
    ³ªÆ®·ý.
  • sodium
    ³ªÆ®·ý(¡­), ¼Òµã(¡­)
  • sodium acetate formalin
    ¾Æ¼¼Æ®»ê³ªÆ®·ý Æ÷¸£¸»¸°
  • sodium balance
    ¼Òµð¿òÆòÇü.
  • sodium bicarbonate test
    ÁßÁ¶½ÃÇè
  • sodium carrier
    ³ªÆ®·ý¿î¹Ýü(¡­ê¡Úæô÷).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • concentrated solution
    ³óÃà¾×(ÒØõêäû)
  • Denhart's solution
    µ§Çϸ£Æ® ¿ë¾×(éÁäû)
  • dilute solution
    Èñ¼®¿ë¾×(ýüà·éÁäû)
  • formal solution
    Æ÷¸£¸» ¿ë¾×(éÁäû)
  • Huebl's iodine solution
    ÈÖºí ¿ä¿Àµå¿ë¾×(éÁäû)
  • hypertonic solution
    °íÀå¾×(ÍÔíåäû)
  • hypotonic solution
    ÀúÀå¾×(î¸íåäû)
  • ideal solution
    ÀÌ»ó ¿ë¾×(×âßÌéÁäû)
  • isoosmolar solution
    µîÀå¾×(Ôõíåäû)
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RLS recursive least square; restless leg syndrome; Ringer lactate solution; Roussy-Levy syndrome
DOSS distal over-shoulder strap; dioctyl sodium sulfosuccinate; docusate sodium
DSS dengue shock syndrome; dioctyl sodium sulfosuccinate; Disability Status Scale; discrete subaortic st...
SB Bachelor of Science; Schwartz-Bartter [syndrome]; serum bilirubin; shortness of breath; sick bay; si...
SPS scapuloperoneal syndrome; shoulder pain and stiffness; simple partial seizures; slow-progressive sch...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
L(+)-LDH) L(+)-lactate dehydrogenase
LD L-Lactate dehydrogenase
LA Lactate
LT Lactate Threshold
[LA] Lactate concentration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium
    ³ªÆ®·ý
    ¹é»öÀÇ ¾ËÄ®¸®¼º ±Ý¼Ó ¿ø¼Ò, Na, ¿øÀÚ ¹øÈ£ 11, ¿øÀÚ·® 22.990, ºñÁß 0.971, ¿øÀÚ°¡ 1.
  • sodium alginate
    ¾ËÁø»ê ³ªÆ®·ý
    ¾à ¾ËÄ®¸®¸¦ »ç¿ëÇÏ¿© °¥»ö ÇØÃʷκÎÅÍ ÃßÃâ Á¤Á¦µÈ ź¼öÈ­¹° ÇöŹ¾× ¿ëÁ¦·Î ¾²ÀδÙ. ¶ÇÇÑ À¯È­ ÀÛ¿ë, ¾ÈÁ¤È­ ÀÛ¿ë, ³óÈ­ ÀÛ¿ë, ¼ö°áÇÕ ÀÛ¿ëÀ» °¡ÁüÀ¸·Î½á À½½Ä¹°, ÀǾàǰ, È­Àåǰ µî¿¡ »ç¿ëµÈ´Ù.
  • sodium benzoate
    ¾È½ÄÇâ»ê ³ªÆ®·ý
    ¾È½ÄÇâ»êÀÇ ³ªÆ®·ý¿°. ¹é»öÀÇ °ú¸³»ó ¶Ç´Â °áÁ¤¼º ºÐ¸». Ç×Áø±Õ¼º ¾àǰ. °£ ±â´É °Ë»ç¿ëÀ¸·Î »ç¿ëµÈ´Ù.
  • sodium biphosphate
    ÀÌÀÎ»ê ³ªÆ®·ý
    ÀλêÀÇ monohydrate ÀÏ ³ªÆ®·ý¿°. ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Ç×Ä®½· °úÀ× Ç÷Á¦, ¼³»ç ¾àÀ¸·Î¼­ ÀÎ»ê ³ªÆ®·ý°ú ÇÔ²² Åõ¿©µÈ´Ù. ¿äÀÇ »ê¼ºÈ­Á¦·Îµµ ¾²ÀδÙ.
  • sodium bisulfite
    Áß¾ÆÈ²»ê ³ªÆ®·ý
    ¾ÆÈ²»ê ¼ö¼Ò ³ªÆ®·ý. ¿©·¯ °¡ÁöÀÇ Á¦¾à¿¡ Ç×»êÈ­Á¦·Î »ç¿ëµÈ´Ù.
  • sodium carbonate
    ź»ê ³ªÆ®·ý
    ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Á¦¾×¿¡¼­ ¾ËÄ®¸®È­ ¾àǰÀ¸·Î »ç¿ëÇÑ´Ù. ¶ÇÇÑ Àμ³À» ÀÏÀ¸Å°´Â ÇǺκ´ÀÇ Ä¡·á¿¡ »ç¿ëÇϸç, ¼¼Á¤Á¦·Îµµ ¾²ÀδÙ.
  • sodium citrate
    ±¸¿¬»ê ³ªÆ®·ý
    C6H5Na3O7. ±¸¿¬»êÀÇ »ï³ªÆ®·ý¿°.
  • sodium exchange resin
    ³ªÆ®·ý ±³È¯ ¼öÁö, ¼Òµð¿ò ±³È¯ ¼öÁö
  • sodium fluoride denitifrice
    ºÒÈ­ ³ªÆ®·ý Ä¡¾à
  • sodium glutamate
    ±Û·çŸ¹Î»ê ³ªÆ®·ý
    ¾Æ¹Ì³ë»êÀÇ ÇϳªÀÎ L-±Û·çŸ¹Î»êÀÇ ³ªÆ®·ý¿°. ÁÁÀº ¸ÀÀ» Áö³à Á¶¹Ì·á·Î¼­ Àß ¾Ë·ÁÁ® ÀÖ´Ù. D-ü´Â Ưº°ÇÑ ¸ÀÀ» Áö´Ï°í ÀÖÁö ¾Ê´Ù. l-±Û·çŸ¹Î»êÀº ³ú ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ¾Ï¸ð´Ï¾Æ¿Í °áÇÕÇØ ±Û·çŸ¹ÎÀÌ µÇ¹Ç·Î ÀúÇ÷´ç È¥¼ö, °£¼º È¥¼ö ½Ã³ª ¾Ï¸ð´Ï¾Æ ÇØµ¶¿¡ »ç¿ëÇÑ´Ù. ´Ù·® »ç¿ë ½Ã¿¡´Â ¾ËÄ®·Î½Ã½º, ¿À½É, ±¸Åä, µÎºÎ ¾Ð¹Ú°¨, µÎÅë µîÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖ´Ù. À̰ÍÀº Á¶¹Ì·á¸¦ ´Ù·® »ç¿ëÇÏ´Â ÁßÈ­ ¿ä¸®¸¦ ¸ÔÀº µÚ¿¡ ÀϾ´Â Á¡¿¡¼­ ÁßÈ­ ¿ä¸®Á¡ ÁõÈıº
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý
    ¹é»öÀÇ °íü. ÀÛ°í µÕ±Ù ¸ð¾ç, ¹ÚÆí ¸ð¾ç, ¸·´ë ¸ð¾ç µî ¿©·¯ ¸ð¾çÀ¸·Î Á¸ÀçÇÑ´Ù. °­ÇÑ ¾ËÄ®¸®¼º. Á¦¾×¿¡¼­ ¾ËÄ®¸®È­Á¦·Î »ç¿ëÇÑ´Ù.
  • sodium hypochlorite
    Â÷¾Æ¿°¼Ò»ê ³ªÆ®·ý
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium monofluorophosphate
    ÀÏ ºÒ¼Ò ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=
  • sodium nitrate
    ¾ÆÁú»ê ³ªÆ®·ý
    ¹é»öÀ̳ª ¾à°£ ³ë¶õ»öÀÇ °ú¸³¼º ºÐ¸», ¹é»öÀÇ ºÒÅõ¸íÇÑ ¿ëÀ¶ µ¢¾î¸® ¶Ç´Â ¸·´ë ¸ð¾ç. û»ê Ä®¸® Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦·Î »ç¿ëÇÑ´Ù. Çù½ÉÁõ, õ½ÄÀÇ °æ¿ì¿¡µµ »ç¿ëµÇ¸ç, º¹Åë, °æ·Ã¼º ´ëÀå¿°°ú °°Àº »óÅ¿¡µµ ÀÌ¿ëµÇ°í ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lactate dehydrogenase isoenzymes <enzyme> Registry number: EC 1.1.1.-
(12 Dec 1998)
lactate dehydrogenase virus A species of RNA virus, probably an arterivirus, occurring in a number of transplantable mouse tumours. Infected mice have permanently elevated serum levels of lactate dehydrogenase.
(12 Dec 1998)
lactate level A test that measures the amount of lactic acid in the blood. Lactic acid is an intermediate product of carbohydrate metabolism and is derived mainly from muscle cells and red blood cells. Exercise will normally raise lactic acid levels. Conditions of oxygen deprivation (for example shock, heart failure, lung disease) will trigger anaerobic metabolism within muscle tissue resulting in lactic acid build up in the tissues. Normal lactic acid levels are 4.5 to 19.8 mg/dl.
(27 Sep 1997)
acetic solution A vinegar.
(05 Mar 2000)
amaranth solution A 1% solution of amaranth (trisodium naphthol sulfonic acid), a synthetic vivid red dye, stable in acid and intensified in sodium hydroxide solution; used as a red or pink colourant in liquid pharmaceuticals.
(05 Mar 2000)
aqueous solution <chemistry> A solution in which water is the dissolving medium or solvent.
(09 Jan 1998)
barium solution A liquid containing barium sulfate, which shows up on X-rays. It outlines organs of the body so they can be seen on X-ray film.
(12 Dec 1998)
Benedict's solution <chemistry> An aqueous solution of sodium citrate, sodium carbonate, and copper sulfate which changes from its normal blue colour to orange, red, or yellow in the presence of a reducing sugar such as glucose.
See: Benedict's test for glucose.
(14 Aug 2000)
Burow's solution A preparation of aluminium subacetate and glacial acetic acid, used for its antiseptic and astringent action on the skin.
(05 Mar 2000)
Gallego's differentiating solution A dilute solution of formaldehyde and acetic acid used in a modified Gram stain to differentiate and enhance the basic fuchsin binding to Gram-negative microorganisms.
(05 Mar 2000)
Gey's solution A salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
(05 Mar 2000)
glucose solution, hypertonic Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.
(12 Dec 1998)
volumetric solution A solution made by mixing measured volumes of the components.
(05 Mar 2000)
chemical solution See: solution.
(05 Mar 2000)
Ringer's solution A solution resembling the blood serum in its salt constituents; it contains 8.6 g of NaCl, 0.3 g of KCl, and 0.33 g of CaCl2 in each 1000 ml of distilled water; used topically for burns and wounds, a salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
See: Ringer's injection.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sodium bicarbonate
    Áßź»ê³ªÆ®·ý 
  • sodium chloride
    ¿°È­³ªÆ®·ý;¼Ò±Ý
  • sodium fluoride
    ºÒÈ­³ªÆ®·ý(¼Òµ¶,¹æºÎÁ¦)
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý 
  • sodium nitrate
    Áú»ê³ªÆ®·ý
  • sodium pentothal
    ÆæÅäÅ»³ªÆ®·ý(¸¶Ãë,ÃÖ¸é¾à¿ë)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á